T-rex: standardized analysis of germline variants in whole-exome sequencing trios
Sara-Luisa Reh, Carolin Walter, Judith Lohse, Tabita Ghete et autres
0 citationsScientific Reports
The US Oncology Network
The Woodlands · US · other
1597Publications signalées
106350Citations signalées
12Thèmes principaux
Principaux domaines
Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapyCancer Immunotherapy and BiomarkersEconomic and Financial Impacts of CancerLung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyEndometrial and Cervical Cancer TreatmentsAdvanced Breast Cancer TherapiesCancer Genomics and DiagnosticsBreast Cancer Treatment StudiesHealth Systems, Economic Evaluations, Quality of Life
Évolution annuelle
Publications récentes
Perioperative Durvalumab for Resectable Non–Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial
John V. Heymach, Jie He, David Harpole, Tetsuya Mitsudomi et autres
0 citationsJournal of Clinical Oncology
Liquid biopsy in oncology practice: A global survey by the Young Committee of the International Society of Liquid Biopsy (ISLB)
Eleonora Nicolò, Surbhi Singhal, Erick Saldanha, Xiao Jin et autres
0 citationsThe Journal of Liquid Biopsy
A Collaborative, Patient-Centered Initiative to Implement Safe and Effective Transitions of Care in Sickle Cell Disease
Cecelia Calhoun, Nirmish Shah, Akshat Jain, Alexandra Walsh et autres
0 citationsJournal of sickle cell disease.
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Participants in Asia With Early Triple-Negative Breast Cancer An Updated Subgroup Analysis of the KEYNOTE-522 Randomized Clinical Trial
Yeon Hee Park, Rina Hui, Seock-Ah Im, Jin-Hee Ahn et autres
0 citationsThe Breast
‘You've Given Me My Voice’—Enhancing Engagement in Exercise Oncology Research: A Patient and Public Involvement Approach to Co‑Designing a Pre‑Radiotherapy Exercise Programme With People Living With Lung Cancer
Matthew Beggs, Joanne Reid, Gerard G. Hanna, Abbie Edgar et autres
0 citationsHealth Expectations
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study
Naomi B. Haas, T.B. Powles, P. Tomczak, S.H. Park et autres
0 citationsAnnals of Oncology
MM-1078: OPTec/OPTal: A Phase 2 Study to Evaluate Outpatient, Step-Up Administration of Teclistamab or Talquetamab With Prophylactic Tocilizumab in Patients With Relapsed/Refractory Multiple Myeloma
Peter Forsberg, David Andorsky, Robert Rifkin, Christopher Yasenchak et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
POSTER: MM-1078: OPTec/OPTal: A Phase 2 Study to Evaluate Outpatient, Step-Up Administration of Teclistamab or Talquetamab With Prophylactic Tocilizumab in Patients With Relapsed/Refractory Multiple Myeloma
Peter Forsberg, David Andorsky, Robert Rifkin, Christopher Yasenchak et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
Pathologic Complete Response Following Frailty-Adjusted Neoadjuvant Paclitaxel in an 88-Year-Old Patient With Radiation-Associated Breast Angiosarcoma
Alyssa C. Brown, Ajay McLaughlin, Kaylyn M Lazuka, Devapiran Jaishankar et autres
0 citationsCureus
A Multi-Timepoint Evaluation of Structured Contouring Training in Radiation Oncology Trainees in Ireland
Maura O'Connell, Ciaran Malone, Jill Nicholson, James Waldron et autres
0 citationsInternational Journal of Radiation Oncology*Biology*Physics
Physician perspectives on the decision-making process for patients with high-risk early-stage triple-negative breast cancer in a community oncology setting
Amin Haiderali, Linda A. Okoth, Srinivas Annavarapu, Paulus Jm et autres
0 citationsFuture Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.